glutaric acid has been researched along with Dry Eye Syndromes in 1 studies
glutaric acid: RN given refers to parent cpd
glutaric acid : An alpha,omega-dicarboxylic acid that is a linear five-carbon dicarboxylic acid.
Dry Eye Syndromes: Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present study, a pterostilbene-peptide amphiphile (PS-GA-RGD) that can spontaneously self-assemble into prodrug nanomedicine, was rationally designed and developed as a novel ophthalmic formulation for the potential management of dry eye." | 7.96 | Preparation and characterization of a pterostilbene-peptide prodrug nanomedicine for the management of dry eye. ( Dai, M; Ding, X; Gong, Q; Hu, L; Hu, Z; Li, K; Li, X; Lin, D; Lu, F; Yu, Y, 2020) |
| "In the present study, a pterostilbene-peptide amphiphile (PS-GA-RGD) that can spontaneously self-assemble into prodrug nanomedicine, was rationally designed and developed as a novel ophthalmic formulation for the potential management of dry eye." | 3.96 | Preparation and characterization of a pterostilbene-peptide prodrug nanomedicine for the management of dry eye. ( Dai, M; Ding, X; Gong, Q; Hu, L; Hu, Z; Li, K; Li, X; Lin, D; Lu, F; Yu, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, L | 1 |
| Hu, Z | 1 |
| Yu, Y | 1 |
| Ding, X | 1 |
| Li, K | 1 |
| Gong, Q | 1 |
| Lin, D | 1 |
| Dai, M | 1 |
| Lu, F | 1 |
| Li, X | 1 |
1 other study available for glutaric acid and Dry Eye Syndromes
| Article | Year |
|---|---|
Preparation and characterization of a pterostilbene-peptide prodrug nanomedicine for the management of dry eye.
Topics: Administration, Ophthalmic; Animals; Anti-Inflammatory Agents; Antioxidants; Delayed-Action Preparat | 2020 |